Skip to content

Isoflavone bioavailability under controlled whole diet conditions

Isoflavone bioavailability under controlled whole diet conditions

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00003493
Enrollment
10
Registered
2012-01-18
Start date
2012-01-17
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy volunteers N95.9

Interventions

Group 1: Isoflavon extract from soy (Novasoy), 1mg/kgBW per day, for 7 days Group 2: placebo for 7 days

Sponsors

Max Rubner-Institut
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
No minimum to 75 Years

Inclusion criteria

Inclusion criteria: postmenopausal women under the age of 75 years; mean BMI of 25 kg/m2; non-smoker; study participants who gave written consent

Exclusion criteria

Exclusion criteria: hormone replacement therapy; history of breast cancer; serious health problems related to nutrient absorption, digestion, metabolism or excretion; women taking nutritional supplements or on medication during the past 3 months, which may interact with study parameters; participants who are supposed to be not complient

Design outcomes

Primary

MeasureTime frame
isoflavone plasma concentrations (LC-MS/MS), before and after isoflavone/placebo supplementation

Secondary

MeasureTime frame
isoflavone metabolites in plasma (LC-MS/MS), before and after isoflavone/placebo supplementation

Countries

Germany

Contacts

Public ContactAnita Kriebel

Max Rubner-Institut

anita.kriebel@mri.bund.de0721 6625413

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026